Kansheng Tu

24PUBLICATIONS
32CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 25, 2026
OTUD1-mediated deubiquitination stabilizes SLC7A11 to suppress ferroptosis in hepatocellular carcinoma.

|Mar 12, 2026
Carbon dot nanozymes as free radical scavengers for the management of hepatic ischemia-reperfusion injury by regulating the liver inflammatory network and inhibiting apoptosis.

Haoge Geng, Jiayu Chen, Kansheng Tu

|Jan 27, 2026
TUFT1 stabilizes TGF-β receptor II protein and facilitates activation of hepatic stellate cells into metastasis-promoting myofibroblasts.

Yue Li, Yu Shi, Yaxin Fu

|May 19, 2025
GTF3C2 Promotes the Proliferation of Hepatocellular Carcinoma Cells through the USP21/MEK2/ERK1/2 Pathway.

Yani Wu, Yingnan Yang, Youju Zhang

|Mar 03, 2025
High glucose facilitates hepatocellular carcinoma cell proliferation and invasion via WTAP-mediated HK2 mRNA stability.

Yongshen Niu, Siying Jia, Xuelian Xiao

|Sep 06, 2024
Nanoreactors with Cascade Catalytic Activity Reprogram the Tumor Microenvironment for Enhanced Immunotherapy by Synchronously Regulating Treg and Macrophage Cells.

Yuhan Fu, Yuanyuan Zhang, Yujie Zhang

Pageof 4

Frequent Collaborators

5 joint publications

Qingguang Liu

3 joint publications

Mingzhen Zhang

2 joint publications

Qiuran Xu

2 joint publications

Zhikui Liu